These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 22186145)

  • 1. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives.
    Hurt AC; Chotpitayasunondh T; Cox NJ; Daniels R; Fry AM; Gubareva LV; Hayden FG; Hui DS; Hungnes O; Lackenby A; Lim W; Meijer A; Penn C; Tashiro M; Uyeki TM; Zambon M;
    Lancet Infect Dis; 2012 Mar; 12(3):240-8. PubMed ID: 22186145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.
    Renaud C; Kuypers J; Englund JA
    J Clin Virol; 2011 Oct; 52(2):70-8. PubMed ID: 21684202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.
    Hurt AC; Deng YM; Ernest J; Caldwell N; Leang L; Iannello P; Komadina N; Shaw R; Smith D; Dwyer DE; Tramontana AR; Lin RT; Freeman K; Kelso A; Barr IG
    Euro Surveill; 2011 Jan; 16(3):. PubMed ID: 21262183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11.
    Storms AD; Gubareva LV; Su S; Wheeling JT; Okomo-Adhiambo M; Pan CY; Reisdorf E; St George K; Myers R; Wotton JT; Robinson S; Leader B; Thompson M; Shannon M; Klimov A; Fry AM;
    Emerg Infect Dis; 2012 Feb; 18(2):308-11. PubMed ID: 22305467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.
    Meijer A; Jonges M; Abbink F; Ang W; van Beek J; Beersma M; Bloembergen P; Boucher C; Claas E; Donker G; van Gageldonk-Lafeber R; Isken L; de Jong A; Kroes A; Leenders S; van der Lubben M; Mascini E; Niesters B; Oosterheert JJ; Osterhaus A; Riesmeijer R; Riezebos-Brilman A; Schutten M; Sebens F; Stelma F; Swaan C; Timen A; van 't Veen A; van der Vries E; te Wierik M; Koopmans M
    Antiviral Res; 2011 Oct; 92(1):81-9. PubMed ID: 21767571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.
    Nguyen HT; Fry AM; Gubareva LV
    Antivir Ther; 2012; 17(1 Pt B):159-73. PubMed ID: 22311680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineages.
    Janies DA; Voronkin IO; Studer J; Hardman J; Alexandrov BB; Treseder TW; Valson C
    Int J Health Geogr; 2010 Feb; 9():13. PubMed ID: 20181276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of oseltamivir resistance in Sydney, during the Newcastle outbreak of community transmitted oseltamivir-resistant influenza A(H1N1)pdm09 virus, Australia, June to August 2011.
    Wang B; Taylor J; Ratnamohan M; McPhie K; Kesson A; Dixit R; Booy R; Hurt A; Saksena N; Dwyer DE
    Euro Surveill; 2012 Jul; 17(27):. PubMed ID: 22790606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase.
    van der Vries E; Jonges M; Herfst S; Maaskant J; Van der Linden A; Guldemeester J; Aron GI; Bestebroer TM; Koopmans M; Meijer A; Fouchier RA; Osterhaus AD; Boucher CA; Schutten M
    J Clin Virol; 2010 Jan; 47(1):34-7. PubMed ID: 19857993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain.
    Ledesma J; Vicente D; Pozo F; Cilla G; Castro SP; Fernández JS; Ruiz MP; Navarro JM; Galán JC; Fernández M; Reina J; Larrauri A; Cuevas MT; Casas I; Breña PP;
    J Clin Virol; 2011 Jul; 51(3):205-8. PubMed ID: 21592854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir.
    Reddy D
    J Antimicrob Chemother; 2010 Apr; 65 Suppl 2(Suppl 2):ii35-ii40. PubMed ID: 20215134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009-2010.
    Ujike M; Ejima M; Anraku A; Shimabukuro K; Obuchi M; Kishida N; Hong X; Takashita E; Fujisaki S; Yamashita K; Horikawa H; Kato Y; Oguchi A; Fujita N; Tashiro M; Odagiri T;
    Emerg Infect Dis; 2011 Mar; 17(3):470-9. PubMed ID: 21392439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus].
    Boibieux A
    Ann Fr Anesth Reanim; 2010 Feb; 29(2):85-6. PubMed ID: 20167451
    [No Abstract]   [Full Text] [Related]  

  • 14. Oseltamivir-resistant pandemic (H1N1) 2009 virus, South Korea.
    Yi H; Lee JY; Hong EH; Kim MS; Kwon D; Choi JH; Choi WY; Kim KS; Lee JK; Oh HB; Kang C
    Emerg Infect Dis; 2010 Dec; 16(12):1938-42. PubMed ID: 21122225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oseltamivir-resistant pandemic (H1N1) 2009 influenza in a severely ill patient: the first Australian case.
    Speers DJ; Williams SH; Pinder M; Moody HR; Hurt AC; Smith DW
    Med J Aust; 2010 Feb; 192(3):166-8. PubMed ID: 20121687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.
    Sheu TG; Deyde VM; Okomo-Adhiambo M; Garten RJ; Xu X; Bright RA; Butler EN; Wallis TR; Klimov AI; Gubareva LV
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3284-92. PubMed ID: 18625765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia.
    Tramontana AR; George B; Hurt AC; Doyle JS; Langan K; Reid AB; Harper JM; Thursky K; Worth LJ; Dwyer DE; Morrissey CO; Johnson PD; Buising KL; Harrison SJ; Seymour JF; Ferguson PE; Wang B; Denholm JT; Cheng AC; Slavin M
    Emerg Infect Dis; 2010 Jul; 16(7):1068-75. PubMed ID: 20587176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community spread and late season increased incidence of oseltamivir-resistant influenza A(H1N1) viruses in Norway 2016.
    Bragstad K; Hungnes O; Litleskare I; Nyrerød HC; Dorenberg DH; Hauge SH
    Influenza Other Respir Viruses; 2019 Jul; 13(4):372-381. PubMed ID: 30834715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A severely immunocompromised child with uncomplicated oseltamivir-resistant 2009 H1N1 pandemic influenza infection.
    Hyle EP; Shu B; Lindstrom S; Klimov A; Hancock K; Ferraro MJ; Traum AZ; Michelow IC
    Pediatr Transplant; 2012 Aug; 16(5):E158-61. PubMed ID: 21429059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment.
    Kossyvakis A; Mentis AA; Tryfinopoulou K; Pogka V; Kalliaropoulos A; Antalis E; Lytras T; Meijer A; Tsiodras S; Karakitsos P; Mentis AF
    Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):361-371. PubMed ID: 27848039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.